CNCR Range Cancer Therapeutics ETF Forecast, Technical & Fundamental Analysis
CNCR in upward trend: 10-day moving average crossed above 50-day moving average on July 16, 2025
The 10-day moving average for CNCR crossed bullishly above the 50-day moving average on July 16, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
CNCR moved above its 50-day moving average on July 16, 2025 date and that indicates a change from a downward trend to an upward trend.
The Aroon Indicator entered an Uptrend today. In of 172 cases where CNCR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Bearish Trend Analysis
Advertisement
General Information
Category Unknown
CNCR and ETFs
Correlation & Price change
A.I.dvisor indicates that over the last year, CNCR has been closely correlated with XBI. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if CNCR jumps, then XBI could also see price increases.
| Ticker / NAME | Correlation To CNCR | 1D Price Change % | ||
|---|---|---|---|---|
| CNCR | 100% | N/A | ||
| XBI - CNCR | 88% Closely correlated | +1.00% | ||
| IBB - CNCR | 81% Closely correlated | +2.87% | ||
| VHT - CNCR | 56% Loosely correlated | +1.83% | ||
| IHI - CNCR | 49% Loosely correlated | +1.02% | ||
| XLV - CNCR | 45% Loosely correlated | +1.86% |